|
CDRI Lucknow to hold industry conclave-cum-panel discussions on Revised Schedule M on Nov 23
|
|
Peethaambaran Kunnathoor, Chennai
November 22 , 2024
|
|
|
Focusing on the Revised Schedule M of the Drugs and Cosmetics Act 1940, the Central Drug Research Institute (CDRI) in Lucknow in Uttar Pradesh will hold one industry conclave-cum-panel discussions on November 23, inviting drug manufacturers, contract research and manufacturing organizations (CRMOs), regulatory service providers (consultants), entrepreneurs of pharma MSMEs and students and researchers from the pharmacy academic field.
The one-day programme will have discussions on various aspects of the Revised Schedule M in addition to areas in drug research. The theme of the seminar is ‘Opportunities and Challenges of Revised Schedule M’, sources from the institute informed Pharmabiz. As part of the program, four panel discussions have been scheduled.
In the regulatory panel, Drug Controller General of India, Dr. Rajeev Singh Raghuvanshi, will be attending to answer the queries of the audience. Other panelists include the state licensing and controlling authority, SM Gupta, deputy commissioner of the UP FSDA, DK Tiwari and Assistant Commissioner of the FSDA, Urmila Agarwal. The programme coordinator Dr. Amit Mishra will be the moderator.
In the medical panel the vice-chancellor of the King George’s Medical University (KGMU), Dr. Sonia Nityanand, senior principal scientist at the Indian Institute of Chemical Biology (IICB) in Kolkata, Dr. Dipyaman Ganguly, Professor of Viral Serology at KGMU, Dr. Vimala Venkatesh, and former chief scientist at the CDRI, Dr. Sharad Sharma will participate as panellists. The director of the Aarupadai Veedu Medical College & Hospital in Pondicherry, Dr. Sarman Singh will be the moderator.
The academic panel discussion will have speakers such as Dr. Shubhini Saraf, director of NIPER, Raebareli, Dr. Sanjay Batra, chief scientist at CDRI, Lucknow, Prof. Padma Devarajan, Dean Research at the Institute of Chemical Technology (ICT), Mumbai and Dr. Saman Habib, chief scientist at CDRI. Dr. Naibedya Chattopadhyay, chief scientist at CDRI will be the moderator.
In the Industry Panel discussions the panellists are Dr. Ashok Omray, a pharmaceutical and academic advisor from Mumbai, ‘Chinu’ Srinivasan, social entrepreneur and co-founder of LOCOST, Vadodara and Hitesh Windlass, managing director of Windlass Biotech Ltd in Dehradun. Vir Anjani Kumar Saxena, president of the Uttar Pradesh Drug Manufacturers Association (UPDMA) will lead the panel discussion as the moderator.
Hailing the CDRI for conducting a panel discussion on the new GMP, Vir Saxena told Pharmabiz that the panel discussion would allow the experts to share their knowledge and insights with the participant industrialists to help them in their efforts to revise the GMP facilities in their units. He said all over Uttar Pradesh there are 150 pharma companies operating and they are all coming under the MSME sector.
As part of the conclave, an exhibition of laboratory technologies, products developed by CDRI, and pharma technologies and pharmaceutical products developed by various firms will be set up at the CDRI. Besides, the CROs and CMOs will have facilities to showcase their products and capabilities. The organizers also set aside space for B2B discussions and campus interviews.
The principal technical officer at the pharmaceutics and pharmacokinetics division of the CDRI informed Pharmabiz that this conclave and panel discussions are part of the activities of a Common Research and Technology Development Hub (CRTDH) in the area of affordable healthcare, funded by the Department of Scientific and Industrial Research, Government of India and the Council of Scientific and Industrial Research. He said the CRTDH is mandated to help MSME firms.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|